The 2022 Annual General Meeting (AGM) of Allergy Therapeutics plc will be held on 7 February 2023 at The Ardington Hotel, Steyne Gardens, Worthing, West Sussex BN11 3DZ at 9:30 am.
Documents related to the meeting can be downloaded below:
Annual Report & Accounts
As previously announced, the publication of our Annual Report and Accounts has been subject to delay this year and we are actively working to finalise this. Once this has been finalised and published for shareholders, a separate general meeting will be convened and held to receive the Directors’ report, the consolidated financial statements and the auditors’ report of the Company for the year ended 30 June 2022. There will be notification of this in due course.
Video conference facility and shareholder questions
We are arranging a video conference facility to provide our shareholders with the opportunity to listen to the AGM and to have their questions answered. If you would like to join the video conference, please contact IR@allergytherapeutics.com by close of business on 3 February 2023 and we will provide a link.
We welcome your questions on the business of the meeting and encourage you to send these questions to IR@allergytherapeutics.com in good time ahead of the meeting. If time and technology permits, we will endeavour to take questions live on the video conference at an appropriate time.
Voting on Resolutions
Please register your proxy vote no later than 09:30 a.m. on 3 February 2023 via our registrar’s website www.signalshares.com, or you may request a paper proxy form from our registrar, or if you are a CREST member via the CREST electronic appointment service. Further details of how to register your proxy vote are contained within the notes to the Notice of AGM. The return of a form of proxy will not preclude a shareholder from attending and voting at the AGM if he/she so wishes. You are urged to appoint the chair of the meeting as your proxy, with voting instructions, in advance of the AGM.